Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Latest filing published 21 Feb 2023 for Lucira Health, Inc., €1,270.
Filing timeline
BuySaleGhazi Kashmolah
Insider track record
Disclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Ghazi Kashmolah: trading record in brief
Ghazi Kashmolah is a declared insider of Lucira Health, Inc. (senior executive), with filings sourced from SEC (Form 4). Between 30 September 2021 and 16 February 2023, the trades on record add up to 10 filings.
Every open-market trade on record is a sale: 9 sales worth €129k. Outside the open market, there are 1 share grant. 2023 to date brings no purchases and 1 sale.
The record was last updated on 21 February 2023 with an open-market sale (€1,270) in Lucira Health, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ghazi Kashmolah
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
5,028 shares@ US$0.271.1% of flowCommon StockSEC:0001209191-23-011047:0
8,011 shares@ US$0.382.6% of flowCommon StockSEC:0001209191-22-060480:0
7,537 shares@ US$0.422.7% of flowCommon StockSEC:0001209191-22-060487:0
4,790 shares@ US$0.351.4% of flowCommon StockSEC:0001209191-22-058008:0
1,500 shares@ US$1.932.6% of flowCommon StockSEC:0001209191-22-047928:0
19,074 shares@ US$2.5242.2% of flowCommon StockSEC:0001209191-22-047309:0
19,074 shares@ US$2.8347.3% of flowCommon StockSEC:0001209191-22-046962:0
197,240 shares0Common StockSEC:0001209191-21-058567:0
8 of 8 declarations
